We found that small interfering RNA-mediated down-regulation of NFKB2 impaired the proliferation, migration and invasion abilities, which mimicked the phenotype of BET inhibitor treatment and SPP1 silencing in melanoma (Figure S9A-D). This evidence concerns the gene NFKB2 and melanoma.